从基于模型的对治疗效果异质性的探索中,在mal de débarquement综合征的潜在教训
Jun Maruta1,2, Sergei B Yakushin1, Catherine Cho3,4
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Frontiers in neurology
|October 22, 2025
概括
登陆不良综合症 (MdDS) 可能涉及错误的速度存储. 数学建模表明,减少速度存储可能会使MdDS拉动感觉恶化,这表明需要联合疗法.
科学领域:
- 神经科学是一个神经科学.
- 垂体系统研究研究 垂体系统研究
- 计算建模 计算建模
背景情况:
- 登陆不良综合症 (MdDS) 是一种慢性前体障碍,其特点是持续的虚假自我运动感觉.
- 这种情况与中央前庭系统内的速度存储机制的潜在不适应有关.
- 目前的治疗方法,包括视觉前体治疗方法,表现出成功,但存在局限性.
研究的目的:
- 调查治疗方法的缺陷,这些治疗方法可以减轻MdDS中的速度存储.
- 使用数学模型探索导致MdDS中"拉动"感觉的潜在神经机制.
主要方法:
- 使用3x3系统矩阵来建模速度存储的三维定向特性.
- 该模型模拟了正常直立姿势和MdDS中改变状态的条件,其特点是横轴合.
- 操纵的关键参数包括速度存储的曲率时间常数和输出重量.
主要成果:
- 数学模型预测,减少速度存储的贡献可以悖论地加剧MdDS患者经历的拉动感觉.
- 这表明减弱速度存储可能会加剧疾病的特定症状.
结论:
- 基于模型的分析表明,MdDS治疗的潜在局限性仅集中在速度存储衰减上.
- 对于患有拉动感的患者,可能需要补充疗法,例如光动力学刺激.
- 需要进一步的研究来完善MdDS的治疗策略.
相关概念视频
Modeling in Therapy
378
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
378
Clearance Models: Noncompartmental Models
240
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
240
Comparing the Survival Analysis of Two or More Groups
551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Model Approaches for Pharmacokinetic Data: Compartment Models
524
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
524
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
317
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
317
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
240
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
240


